These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 3567961)
1. Cholinergic influence on manic symptoms. Krieg JC; Berger M Clin Neuropharmacol; 1986; 9 Suppl 4():544-6. PubMed ID: 3567961 [No Abstract] [Full Text] [Related]
2. RS 86 in manic disorder. van Berkestijn H; van der Meulen LM; Flentge F; Dols L; van den Hoofdakker R Biol Psychiatry; 1990 Jan; 27(1):109-12. PubMed ID: 2404521 [No Abstract] [Full Text] [Related]
3. Treatment of mania with the cholinomimetic agent RS 86. Krieg JC; Berger M Br J Psychiatry; 1986 May; 148():613. PubMed ID: 3535973 [No Abstract] [Full Text] [Related]
4. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders. Berger M; Riemann D; Krieg C Acta Psychiatr Scand Suppl; 1991; 366():52-60. PubMed ID: 1897376 [TBL] [Abstract][Full Text] [Related]
6. Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. Kato T; Inubushi T; Takahashi S J Clin Psychopharmacol; 1994 Oct; 14(5):330-5. PubMed ID: 7806688 [TBL] [Abstract][Full Text] [Related]
7. [A study of the concentration of lithium in the blood following treatment of patients with manic-depressive psychosis]. Mikhalenko IN; Leont'ev VG Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):279-84. PubMed ID: 4743282 [No Abstract] [Full Text] [Related]
8. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Hollander E; Davidson M; Mohs RC; Horvath TB; Davis BM; Zemishlany Z; Davis KL Biol Psychiatry; 1987 Sep; 22(9):1067-78. PubMed ID: 3651528 [TBL] [Abstract][Full Text] [Related]
10. Manic symptoms and quality of life in bipolar disorder. Gazalle FK; Hallal PC; Andreazza AC; Frey BN; Kauer-Sant'Anna M; Weyne F; da Costa SC; Santin A; Kapczinski F Psychiatry Res; 2007 Sep; 153(1):33-8. PubMed ID: 17544154 [TBL] [Abstract][Full Text] [Related]
11. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment. Harvey PD; Endicott JM; Loebel AD Bipolar Disord; 2008 Dec; 10(8):900-6. PubMed ID: 19594505 [TBL] [Abstract][Full Text] [Related]
12. Is bipolar I disorder heterogeneous? Angst J; Gerber-Werder R; Zuberbühler HU; Gamma A Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):82-91. PubMed ID: 15146337 [TBL] [Abstract][Full Text] [Related]
13. Absorption and excretion of lithium in manic-depressive disease. Platman SR; Rorlich J; Fieve RR Dis Nerv Syst; 1968 Nov; 29(11):733-8. PubMed ID: 5717288 [No Abstract] [Full Text] [Related]
14. Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Serretti A; Artioli P; Zanardi R; Rossini D Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):751-7. PubMed ID: 12921905 [TBL] [Abstract][Full Text] [Related]
15. The effect of haloperidol on serum levels of lithium in adult manic patients. Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599 [No Abstract] [Full Text] [Related]
16. [Preliminary experience with the lithium therapy of manic-depressive psychoses]. Berzewski H; Kanowski S Act Nerv Super (Praha); 1970 Jan; 12(1):35-42. PubMed ID: 5418650 [No Abstract] [Full Text] [Related]